News

We provide the latest news
from the world of economics and finance

Back
09 May
Why Cardlytics Stock Collapsed on Thursday

Shares of advertising technology company Cardlytics (NASDAQ: CDLX) imploded Thursday morning, falling 32% through 10:15 a.m. ET after reporting what -- in all honesty -- didn't look like much of a miss last night.

Expected to report quarterly sales of $71.7 million in Q1, Cardlytics said it booked only $67.6 million in sales. However, Cardlytics actually beat average earnings estimates, losing only $0.09 per share where Wall Street had forecast an $0.11 loss.

How bad were Cardlytics Q1 earnings?

Now, this is not to say the news was good, exactly. The $0.09 loss that analysts are focusing on today was actually a non-GAAP number. When calculated according to generally accepted accounting principles (GAAP), Cardlytics' loss was a much steeper $0.56 per share -- and a reversal from last year's Q1 profit of $0.40 per share.

Still, revenues grew 5% year over year, and billings (which can foreshadow future revenue growth) were up by 10%.

Is Cardlytics stock a sell?

What's curious, however, is that while strong billings growth usually implies strong sales growth (at least over time), Cardlytics' guidance for Q2 was actually not that great. Q2 revenue is now forecast to range from only 6% growth to a 5% decline -- so basically flat at the midpoint, and definitely not up 10%.

About the only good news I see is that Cardlytics forecasts its billings to grow 5% to 15% next quarter, so 10% at the midpoint, just like in Q1. Eventually, you have to expect double-digit billings growth will transform into double-digit sales growth -- and ideally, a bit of profits growth as well.

But the emphasis is on "eventually." For the time being, investors are more focused on the fact that Cardlytics stock is losing money now, and quite a lot of it. They're selling the stock for this reason, and I cannot say I blame them.

Should you invest $1,000 in Cardlytics right now?

Before you buy stock in Cardlytics, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Cardlytics wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $553,959!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

*Stock Advisor returns as of May 6, 2024

Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.